Invizyne Technologies Inc/$EXOZ
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Invizyne Technologies Inc
EXoZymes Inc is focused on using a biomanufacturing platform to create valuable biochemicals, including Active Pharmaceutical Ingredients or APIs, biofuels, food flavors, and cosmetics, offering a sustainable alternative to traditional chemical production methods. The company believes its platform will enable scalable production of chemical molecules found in nature in a process that is alternative to and more environmentally friendly and sustainable than the typical methods used today, such as chemical synthesis, natural extraction, and synthetic biology.
Ticker
$EXOZ
Sector
Primary listing
Employees
32
Headquarters
Website
EXOZ Metrics
BasicAdvanced
$39m
-
-$1.15
-
-
Price and volume
Market cap
$39m
52-week high
$18.40
52-week low
$4.35
Average daily volume
13k
Financial strength
Current ratio
1.321
Quick ratio
1.104
Long term debt to equity
54.315
Total debt to equity
76.231
Profitability
EBITDA (TTM)
-9.861
Effective tax rate (TTM)
1.08%
Management effectiveness
Return on assets (TTM)
-81.64%
Return on equity (TTM)
-185.84%
Valuation
Price to book
25.8
Price to tangible book (TTM)
25.8
Price to free cash flow (TTM)
-5.512
Free cash flow yield (TTM)
-18.14%
Free cash flow per share (TTM)
-0.844
Growth
Earnings per share change (TTM)
21.67%
EXOZ News
AllArticlesVideos
eXoZymes Selected for DoE's Genesis Mission to Advance AI-Powered Digital Twins for Cell-Free Biomanufacturing
Accesswire·1 week ago
eXoZymes Awarded $2 Million NIH Grant to Advance Cannabinoid Analogs for Drug Discovery
Accesswire·1 month ago
eXoZymes Inc. Announces Closing of $6 Million Public Offering
Accesswire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.